You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Boehringer Ingelheim
Moodys
Merck
McKinsey

Last Updated: October 24, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BESIFLOXACIN HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Besifloxacin Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00347932 A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis. Completed Bausch & Lomb Incorporated Phase 3 2006-06-01 Evaluation of the clinical and microbial efficacy of 0.6% ISV-403, compared to vehicle in the treatment of bacterial conjunctivitis.
NCT00348348 A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis Completed Bausch & Lomb Incorporated Phase 3 2006-06-01 This is a study to investigate a novel drug candidate for the treatment of bacterial conjunctivitis.
NCT00407589 Systemic Pharmacokinetics of BOL-303224-A Completed Bausch & Lomb Incorporated Phase 1 2006-10-01 This is a multi-center, open-label, single dose/multiple dose, pharmacokinetic study in participants with bacterial conjunctivitis. The purpose of this study is to determine the extent of systemic exposure to BOL-303224-A following single and multiple topical administration of BOL-303224-A in participants with suspected bacterial conjunctivitis.
NCT00622908 Clinical and Microbial Efficacy of ISV403 in Bacterial Conjunctivitis Completed Bausch & Lomb Incorporated Phase 2 2004-12-01 To evaluate the clinical and microbial efficacy of ISV-403 administered three times a day (TID) for 5 days compared to vehicle three times a day for 5 days in the treatment of bacterial conjunctivitis
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Besifloxacin Hydrochloride

Condition Name

Condition Name for Besifloxacin Hydrochloride
Intervention Trials
Bacterial Conjunctivitis 5
Acute Bacterial Conjunctivitis 2
Cataract Extraction 2
Congenital Nasolacrimal Duct Obstruction 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Besifloxacin Hydrochloride
Intervention Trials
Conjunctivitis, Bacterial 8
Conjunctivitis 8
Cataract 5
Eye Injuries, Penetrating 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Besifloxacin Hydrochloride

Trials by Country

Trials by Country for Besifloxacin Hydrochloride
Location Trials
United States 14
Canada 1
Mexico 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Besifloxacin Hydrochloride
Location Trials
New York 5
New Jersey 2
Tennessee 1
Pennsylvania 1
Massachusetts 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Besifloxacin Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Besifloxacin Hydrochloride
Clinical Trial Phase Trials
Phase 4 3
Phase 3 5
Phase 2/Phase 3 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Besifloxacin Hydrochloride
Clinical Trial Phase Trials
Completed 11
Terminated 3
Unknown status 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Besifloxacin Hydrochloride

Sponsor Name

Sponsor Name for Besifloxacin Hydrochloride
Sponsor Trials
Bausch & Lomb Incorporated 12
Bucci Laser Vision Institute 1
Innovative Medical 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Besifloxacin Hydrochloride
Sponsor Trials
Industry 13
Other 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
McKinsey
Baxter
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.